Activity | Visits | ||||||||||
0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
Donor demographic data | X | ||||||||||
Graft characteristics | X | ||||||||||
Recipient clinical and demographic data | X | ||||||||||
• Clinical and laboratory data: • Anthropometric parameters • Delayed graft function • Anticalcineurin levels • Fasting blood glucose and hypoglycemic treatment • Serum creatinine • Estimated filtration (CKD-EPI) • Ultrasensitive C-reactive protein (PCR) • Acute rejection • Data ○ Histological Type (Banff Classification ‘19) ○ Treatment received ○ Corticosensitive/Corticoresistant ○ Serum creatinine at the start of treatment • BP, total cholesterol, HDL-cholesterol and LDL-cholesterol values • Proteinuria: protein / creatinine ratio or 24-hour proteinuria • Infections • Medical and surgical complications • Concomitant drugs | X | X | X | X | X | X | X | X | X | ||
Informed consent | X | ||||||||||
Protocol biopsy | X | X | |||||||||
Anti-HLA antibodies | X | X | X | X | X | X | |||||
Assessment of therapeutic compliance | X | X | X |